Osteopenia and osteoporosis are also highly prevalent in HD patients due to abnormal CKD-related homeostasis, elevated phosphate and fibroblast growth factor-23 (FGF-23), and reduced vitamin D and calcium levels, leading to secondary hyperparathyroidism and impaired bone remodeling [8,9]. This evidence concerns the gene FGF23 and chronic kidney disease.